Single giant unilamellar vesicle method reveals effect of antimicrobial peptide magainin 2 on membrane permeability.
It is thought that magainin 2, an antimicrobial peptide, acts by binding to lipid membranes. Recent studies using a suspension of large unilamellar vesicles (LUVs) indicate that magainin 2 causes gradual leakage from LUVs containing negatively charged lipids. However, the details of the characteristics of the membrane permeability and the mechanism of pore formation remain unclear. In this report, we investigated the interaction of magainin 2 with single giant unilamellar vesicles (GUVs) composed of a dioleoylphosphatidylcholine and dioleoylphosphatidylglycerol mixture (50% DOPG/50% DOPC GUVs) containing the fluorescent dye, calcein, by phase contrast, fluorescence microscopy using the single GUV method. Low concentrations (3-10 microM) of magainin 2 caused the rapid leakage of calcein from single GUVs but did not disrupt the liposomes or change the membrane structure, showing directly that magainin 2 forms membrane pores through which calcein leaked. The rapid leakage of calcein from a GUV started stochastically, and once it began, the complete leakage occurred rapidly (6-60 s). The fraction of completely leaked GUV, P(L), increased with time and also with an increase in magainin 2 concentration. Shape changes in these GUVs occurred prior to the pore formation and also at lower concentrations of magainin 2, which could not induce the pore formation. Their analysis indicates that binding of magainin 2 to the external monolayer of the GUV increases its membrane area, thereby raising its surface pressure. The addition of lysophosphatidylcholine into the external monolayer of GUVs increased P(L). On the basis of these results, we propose the two-state transition model for the pore formation.
Tamba
Yukihiro
Y
Materials Science, Graduate School of Science and Engineering, Shizuoka University, Shizuoka 422-8529, Japan.
Yamazaki
Masahito
M
D023181:Antimicrobial Cationic Peptides / Q000494:pharmacology*; D005452:Fluoresceins / Q000737:chemistry; D008081:Liposomes / Q000737:chemistry*; D008244:Lysophosphatidylcholines / Q000494:pharmacology; D054806:Magainins; D010539:Permeability / Q000187:drug effects*; D010715:Phosphatidylglycerols; D029867:Xenopus Proteins / Q000494:pharmacology*
D023181:Antimicrobial Cationic Peptides; D005452:Fluoresceins; D008081:Liposomes; D008244:Lysophosphatidylcholines; D054806:Magainins; D010715:Phosphatidylglycerols; D029867:Xenopus Proteins; C053301:magainin 2 peptide, Xenopus; C051388:1,2-dioleoyl-sn-glycero-3-phosphoglycerol; C007740:fluorexon